Skip to main content
Average ER Wait Time
Checking ER Wait Time
The feed could not be reached
Adult ER
RMHC Pediatric ER

Bone Cancer

Bone Cancer Diagnosis

Most bone cancers begin with a concern about a lesion – a region in an organ or tissue that has suffered damage through injury or disease, such as a wound, ulcer, abscess or tumor.

Once a patient arrives at Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s Medical Center, a physician meets with them to determine whether a biopsy of the lesion is necessary. If it is needed, a patient may have his or her biopsy administered at Presbyterian/St. Luke’s or they could be sent to an interventional radiologist.

Most bone biopsies are minimally invasive, and completed using a needle. On rare occasion, an open biopsy (surgery) is needed to diagnose. Results are given typically within 48 hours.

At Presbyterian/St. Luke’s, we treat all types of bone and soft tissue tumors, both benign and malignant. After we confirm the diagnosis pathologically, our doctors discuss individual options for the patient, including prognosis, treatment and future plans.

Multi-Disciplinary Expert Review

Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s provides patients with a group of expert physicians who meet weekly to review each individual bone cancer case and collaboratively develop a comprehensive care plan. These conferences are a part of the global Sarah Cannon sarcoma network.

Our program is designed to provide care that goes well beyond just diagnosis and treatment. During meetings, physicians discuss individual patient management, go over findings and recommend therapies specific to each patient.

Members of a multi-disciplinary care team include:

  • Orthopedic oncologist
  • Medical oncologist
  • Interventional radiologist
  • Diagnostic radiologist
  • Plastic and reconstructive surgeon
  • Nurse navigator

Bone Cancer Treatment

Presbyterian/St. Luke’s treats bone and soft tissue sarcomas and metastatic lesions. The bone cancer care team in Denver employs modern techniques and focuses on their unique approach to osteosarcoma treatment with a protocol they have developed. Presbyterian/St. Luke’s is a leader in survival rates in adult and pediatric osteosarcoma.

One of the most exciting techniques for osteosarcoma at Presbyterian/St. Luke’s is our intra-arterial chemotherapy preoperatively in the treatment of osteosarcoma. We offer a full line of limb sparing technologies for adult and pediatric tumor patients including expandable prostheses in children.  

If you have been diagnosed with bone cancer, you will likely be treated with surgery, radiation, chemotherapy or targeted therapy.